-
WHEN TRIALS FALL SHORT: LEVERAGING REAL-WORLD EVIDENCE TO ADVANCE PRECISION THERAPIES
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH PREOPERATIVE HEALTH-RELATED QUALITY OF LIFE IN PATIENTSUNDERGOING SURGERYFOR DEGENERATIVE LUMBAR SPINE CONDITIONS: A CROSS-SECTIONAL EQ-5D STUDYIN A MULTI-ETHNIC ASIAN POPULATION
Mar 18, 2026, 21:38 PM -
LEVERAGING AI-DRIVEN NATURAL LANGUAGE PROCESSING TO ENHANCE SYMPTOM CAPTURE IN PRIMARY BILIARY CHOLANGITIS (PBC) AND PRIMARY SCLEROSING CHOLANGITIS (PSC)
Mar 18, 2026, 21:38 PM -
ELECTRONIC HEALTH RECORDS VERSUS ADMINISTRATIVE CLAIMS TO SUPPORT PHARMACOVIGILANCE REVIEW OF SAFETY EVENTS: A FIT-FOR-PURPOSE EVALUATION
Mar 18, 2026, 21:38 PM -
THE HERCULES STUDY: METHODS AND RATIONALE OF ASSESSING THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS LIVING WITH EARLY-STAGE CHRONIC KIDNEY DISEASE AND THEIR CARERS IN THE US
Mar 18, 2026, 21:38 PM -
EVALUATING INITIAL MEDICATION ADHERENCE THRESHOLDS AS PREDICTORS OF CONTINUATION ADHERENCE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A CLAIMS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
GIVE ME THE NUMBERS: FINE-GRAINED, STRUCTURED DATA EXTRACTION BEYOND NARRATIVE LLM OUTPUTS
Mar 18, 2026, 21:38 PM -
OPTIMIZATION OF PROSTATE CANCER BIOPSY DECISION-MAKING IN KOREAN PATIENTS USING MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
EVALUATING THE COST EFFECTIVENESS OF HPV VACCINATION IN EGYPT
Mar 18, 2026, 21:38 PM -
CULTURAL ADAPTATION AND LINGUISTIC VALIDATION OF THE CANCER AWARENESS MEASURE FOR INDIVIDUALS WITH INTELLECTUAL DISABILITIES IN HUNGARY
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARATIVE EFFECTIVENESS AND SAFETY OF TERLIPRESSIN VERSUS CONVENTIONAL THERAPY IN HOSPITALIZED ADULTS WITH HEPATORENAL SYNDROME
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN IN PEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
CURATING FIT-FOR-PURPOSE GEOGRAPHIC REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
PREDICTORS OF 30-DAY HOSPITAL READMISSION AMONG PATIENTS WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
ENDOCRINE RESISTANCE AND REAL-WORLD TREATMENT PATTERNS AFTER FIRST-LINE (1L) ET+CDK4/6I IN HR+/HER2-METASTATIC BREAST CANCER (MBC)
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE PATIENT JOURNEY, HEALTH CARE RESOURCE UTILIZATION, AND ECONOMIC IMPACT OF PATIENTS WITH PTLD: A U.S. CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
BORROWING STRENGTH WITHOUT BORROWING BIAS IN ONCOLOGY USING POWER PRIORS AND COMMENSURATE PRIORS FOR LONG TERM OVERALL SURVIVAL EXTRAPOLATION
Mar 18, 2026, 21:38 PM -
OPTIMIZING ENDPOINTS FOR CRSWNP BIOLOGIC TRIALS: REGULATORY, HTA, AND PATIENT-CENTERED EVIDENCE REQUIREMENTS
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION AND BUDGET IMPACT ANALYSIS OF THE TRANSCATHETER PULMONARY VALVE VERSUS SURGICAL REPLACEMENT FOR RVOT DYSFUNCTION IN MEXICO
Mar 18, 2026, 21:38 PM -
DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS
Mar 18, 2026, 21:38 PM
